Militia Long/Short Equity ETF(ORR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORR Militia Long/Short Equity ETF

盘前交易 10-28 04:33:45 EDT

38.92

-0.22

-0.56%

最高39.16	最低38.76	成交量8.10万
今开39.01	昨收39.14	日振幅1.02%
总市值3.52亿	流通市值3.52亿	总股本904.00万
成交额315.02万	换手率0.90%	流通股本904.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORR","market":"US","secType":"STK","nameCN":"Militia Long/Short Equity ETF","latestPrice":38.92,"timestamp":1793131200000,"preClose":39.14,"halted":0,"volume":80967,"delay":0,"changeRate":-0.005620848237097569,"floatShares":9040000,"shares":9040000,"eps":0,"marketStatus":"盘前交易","change":-0.22,"latestTime":"10-28 04:33:45 EDT","open":39.01,"high":39.16,"low":38.7601,"amount":3150218.69448,"amplitude":0.010217,"askPrice":61.85,"askSize":100,"bidPrice":37.01,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793194200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":38.92,"sharesOutstanding":12720000,"nav":38.92,"aum":351836800,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.92,"preClose":38.92,"latestTime":"19:30 EDT","volume":9,"amount":350.28,"timestamp":1793143800359,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.9252920004502598,"impliedVol":0.2156,"impliedVolPercentile":0.7241},"requestUrl":"/m/hq/s/ORR","defaultTab":"news","newsList":[{"id":"2678149129","title":"九大研究贯通两大板块：艾帕洛利托沃瑞利单抗以全病程布局回应消化道肿瘤之困","url":"https://stock-news.laohu8.com/highlight/detail?id=2678149129","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678149129?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:13","pubTimestamp":1793088780,"startTime":"0","endTime":"0","summary":"  编者按：2026年欧洲肿瘤内科学会(ESMO)年会于10月23日至27日在西班牙马德里召开，作为全球肿瘤领域最具影响力的学术盛会之一，ESMO始终聚焦前沿诊疗进展，引领临床实践变革方向。本届年会 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261027/c681134750.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261027/c681134750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BITY","BETH","CBOO","BTCO","BCCC","BFJL","BTCL","IBIT","CBXJ","HPEL","HPE","CBOY","ADC","CBXO","L","CBTY","GBTC","HODL","BPI","MAXI","CBOA","BAGY","PFS","YBTC","BTF","BTC","XBTY","CR","FXN","BTCW","BITU","PR","BITX","BTCI","MNRS","CBXY","SD","BFAP","CBOJ","PXI","FBTC","NETL","BTRN","MSS","CBTJ","BTCC","ORR","BITO","CBXA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678673061","title":"泽璟制药：2026年ESMO年会ZG006确认ORR最高91.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678673061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678673061?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:05","pubTimestamp":1793012737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677276908","title":"CLDN18.2靶向ADC 3期研究达到双主要终点；双靶点ADC 3期结果积极……","url":"https://stock-news.laohu8.com/highlight/detail?id=2677276908","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677276908?lang=zh_cn&edition=full","pubTime":"2026-10-24 07:35","pubTimestamp":1792798500,"startTime":"0","endTime":"0","summary":" CLDN18.2靶向ADC国际3期研究达到双主要终点，延长胃癌患者PFS和OS 武田(Takeda)和信达生物(Innovent Biologics)公布了在研CLDN18.2靶向抗体偶联药物(ADC)arcotatug tava ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0306806265.USD","ADC","BK4559","LU0432979614.USD","LU0237698245.USD","IHE","LU1430594728.SGD","LU2242646821.SGD","LU0985481810.HKD","LU0096364046.USD","IE0009355771.USD","ORR","LU1670711040.USD","LU1074936037.SGD","LU1032466523.USD","IE00BFXG1179.USD","LU1261432733.SGD","LU1670710661.SGD","LU1670711123.USD","LU1868837136.USD","BK4231","LU0321505868.SGD","LU2596442595.SGD","BK4211","LU0114720955.EUR","BK4585","IE00BFTCPJ56.SGD","LU1236620750.USD","ITT","IE00BSNM7G36.USD","BK4532","FTXH","LU1291159041.SGD","LU0225284248.USD","LU0456855351.SGD","LU1983299246.USD","BK4139","LU1571399168.USD","LU2133065610.SGD","GMAB","NETL","LU2360032135.SGD","LU0061475181.USD","BMY","LU2125154935.USD","BK4581","PFS","FFBC","BK4534","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677979202","title":"原油盘中涨近4%，布油冲上117美元，中东风险持续、空头回补加把火","url":"https://stock-news.laohu8.com/highlight/detail?id=2677979202","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677979202?lang=zh_cn&edition=full","pubTime":"2026-10-24 01:14","pubTimestamp":1792775671,"startTime":"0","endTime":"0","summary":"中东能源供应风险持续升温，叠加周末前空头回补及期权对冲买盘，国际原油进一步走高。美东时间23日周五美股早盘时段，美国WTI原油一度逼近103.30美元/桶，日内涨幅超过3.8%；布伦特原油一度突破117.40美元/桶，日内涨近3.8%。布油年内累计涨幅已超过85%，中东冲突引发的供应风险溢价仍是支撑油价的重要力量。","market":"sh","thumbnail":"https://static.tigerbbs.com/90b557d4f9e36e20bc3bd3ba410e27e5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/90b557d4f9e36e20bc3bd3ba410e27e5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3784356","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBE","MCLmain","PXJ","WTIU","IEO","XES","CLmain","UCO","DBC","FLBR","CLSE","USO","UUP","OILU","VDE","GUSH","BZmain","BK4588","DIG","DWT","FAAR","UDN","OILK","BNO","USL","PXE","XOP","USOI","OIH","DUG","DBO","SCO","FBZ","UGA","DRIP","DRLL","BK4570","FTXN","ORR","QMmain","SHRT","USE","DDG","BK4585","OILT","PRMN","IXC","WTLS","ERX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675591106","title":"德银：黄金量化抛压接近“绝对耗尽”，CTA空头回补或点燃Q4反弹行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591106","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591106?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:40","pubTimestamp":1792150858,"startTime":"0","endTime":"0","summary":"德银认为，量化基金风险平价组合去杠杆规模已达2010年以来第90百分位，黄金算法卖盘接近\"绝对耗尽\"，CTA空头回补或形成自我强化的买入循环，支撑四季度金价走强。不过，金价仍需突破约4370美元/盎司才能触发新一轮大规模程序化买入。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3783795","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISMF","DBMF","DUST","JPFP","USG","OUNZ","GLL","GDXJ","GCmain","GLTR","IAU","BAR","DGP","AAAU","IAUM","BTGD","SGDM","JNUG","GBUG","MGCmain","JDST","IAUI","PICK","PRMN","GOAU","GOLY","WTLS","SGOL","XME","PALL","SDMF","CLSE","GDXY","UGL","GDXD","BEGS","TFPN","GDXU","1OZmain","UYM","FGDL","02840","DZZ","PHYS","FAAR","ORR","DBC","GDX","159831","DULL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675732483","title":"劲方医药-B(02595.HK)：GFH375/VS-7375多项国内及海外临床研究取得积极进展，在多种 RAS 突变实体瘤中显示优秀疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2675732483","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675732483?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:02","pubTimestamp":1792022533,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4213","LU0456854461.SGD","BK4195","ORR","CRC","LU0266512127.USD","BK4211","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116157","title":"交易员：布雷曼讲话引发空头回补，纽元兑美元上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669116157?lang=zh_cn&edition=full","pubTime":"2026-09-22 14:11","pubTimestamp":1790057471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UUP","CLSE","SHRT","UDN","PRMN","ORR","WTLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669515363","title":"EGFR ex20ins赛道进入冲刺赛：伏美替尼申报一线适应症 国产双药同台竞技","url":"https://stock-news.laohu8.com/highlight/detail?id=2669515363","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669515363?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:19","pubTimestamp":1789975140,"startTime":"0","endTime":"0","summary":"迪哲医药的舒沃替尼、艾力斯的伏美替尼两大国产明星靶向药相继突破，国内EGFR ex20ins治疗格局有望改写。伏美替尼入局20ins一线审批国产双药同台竞技创新药赛道的竞争，本质是时间的竞争。依托WU-KONG28研究的重磅阳性结果，舒沃替尼一线EGFR ex20ins适应症上市申请于2026年5月正式获NMPA受理，并同步纳入优先审评程序。整体来看，2026年底至2027年，国内EGFR ex20ins一线赛道或将迎来双药集中获批的关键窗口期。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-21/doc-inisqkzy8948524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4195","PFS","ORR","BK4211","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658657","title":"港股异动 | 映恩生物-B涨超9%，DB-1311联用Pumitamig WCLC摘要披露，一线SCLC ORR达92.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658657","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667658657?lang=zh_cn&edition=full","pubTime":"2026-09-14 14:38","pubTimestamp":1789367907,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B涨超9%，截至发稿，涨8.48%，报183港元，成交额1.65亿港元。消息面上，世界肺癌大会更新了映恩生物与BioNTech共同开发的B7-H3 ADC BNT324/DB-1311联合PD-L1×VEGF-A双抗Pumitamig治疗晚期肺癌的Ib/II期数据：截至2026年7月7日，71例可评估小细胞肺癌患者整体客观缓解率为70.4%，其中一线92.3%、二线77.3%、三线及以上52.4%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b772ac54294987140db862d7556db12e","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b772ac54294987140db862d7556db12e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495543.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"映恩生物 DB-1311联用Pumitamig WCLC摘要披露，一线SCLC ORR达92.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ORR","HK0000500386.USD","09606","HK0000252160.HKD","KCAI","HK0000252152.HKD","BK4585","LU2543165471.USD","VXUS","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666798529","title":"创新药将迎数据催化窗口！OS、PFS、ORR还都分不清楚？速查指南来了！收藏备用","url":"https://stock-news.laohu8.com/highlight/detail?id=2666798529","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666798529?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:22","pubTimestamp":1789125720,"startTime":"0","endTime":"0","summary":"创新药重磅提示！就在周六，2026年WCLC将正式开幕，康方生物、石药集团、科伦博泰生物等诸多创新药龙头公司将公布旗下核心产品临床数据。III期达到终点，意味着获批概率大幅提升，属于实质性大利好。临床试验中通常报告“中位OS”，即50%患者存活的时间。FDA加速批准程序允许基于替代终点批准药物，但上市后需完成确证性试验。FDA规定，提交后30天内若无异议，IND自动生效。以优效性为目标的头对头试验证据级别最高。权重数据截至2026.8.31。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrw8907408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MEDX","159992","BK1574","IBBQ","ORR","LNGR","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583697","title":"迪哲医药：比瑞替尼II期研究发表，ORR达47.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583697?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:48","pubTimestamp":1788940107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660047782","title":"减持警报暂解？亿万富翁沃尔特质押Carvana(CVNA.US)股份 空头回补推动股价反弹逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660047782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660047782?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:06","pubTimestamp":1787191592,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4503","CLIX","ORR","CVNA","CVNY","LU0175139822.USD","LU0289960550.SGD","BK4548","IE00BD6J9T35.USD","SHRT","CVNX","BK4585","BK4214","LU0133085943.USD","BK4588","WTLS","CLSE","PRMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657280621","title":"SpaceX解禁后两日暴涨23%，期权成交创纪录，空头回补或进一步推升股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2657280621","media":"华尔街见闻","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657280621?lang=zh_cn&edition=full","pubTime":"2026-08-08 06:48","pubTimestamp":1786142899,"startTime":"0","endTime":"0","summary":"SpaceX两日市值激增3270亿美元，股价重新逼近135美元IPO发行价。周五截至纽约时间下午1时50分，SpaceX期权成交量达到224万份合约，其中看涨期权成交量达到130万份，创历史新高。目前仍有超过2.5亿股SpaceX股票被卖空，股价快速上涨，空头被迫回补可能进一步推升股价。","market":"sh","thumbnail":"https://static.tigerbbs.com/f16a7a67d0d2e6f1e72c43b8fe10d226","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f16a7a67d0d2e6f1e72c43b8fe10d226"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6c5b1e98ab57449e9a363569b6b7313b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3778979","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"SpaceX解禁后两日暴涨23%，期权成交创纪录，空头回补或进一步推升股价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4615","SHRT","CLSE","SPAL","LU2360107168.USD","SPCG","XOVR","SSPC","SPCX","ORR","SPAX","SPCM","PRMN","LOFF","LU1861559042.SGD","SPCF","WTLS","SPCQ","UFO","MARS","WARP","DXYZ","WSPC","SPCH","LU2290526834.HKD","LU1861220033.SGD","LU1861558580.USD","LU1861215975.USD","SPCU","ORBX","BK4089","SNK"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657644945","title":"美股异动 | SpaceX(SPCX.US)涨逾8% 限售股解禁未现抛压 空头回补推动股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644945","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644945?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:26","pubTimestamp":1786112794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ORR","PRMN","UFO","SPCM","WSPC","SPCG","SPAX","CLSE","BK4615","DXYZ","WARP","LU2360107168.USD","XOVR","SPCX","LU1861558580.USD","SPAL","LU2290526834.HKD","SHRT","SPCF","SPCH","SPCU","MARS","SPCQ","LOFF","LU1861220033.SGD","WTLS","BK4089","SSPC","LU1861559042.SGD","SNK","LU1861215975.USD","ORBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656634286","title":"多家机构判断：中国新能源车空头回补仍将持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2656634286","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656634286?lang=zh_cn&edition=full","pubTime":"2026-08-03 10:55","pubTimestamp":1785725750,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SHRT","WTLS","KBA","CLSE","PRMN","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656566349","title":"花旗：汽车股空头回补料持续 新能源汽车销量明显提升等利好支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2656566349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656566349?lang=zh_cn&edition=full","pubTime":"2026-08-03 08:39","pubTimestamp":1785717558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0170899867.USD","LU0128525689.USD","LU1366192091.USD","LU0314106906.USD","LU0203345920.USD","BK4504","IE00BSNM7G36.USD","LU0106831901.USD","LU0980610538.SGD","BK4207","LU2125154935.USD","LU2462157665.USD","CARU","LU0648001328.SGD","LU1506573853.SGD","BK4534","LU2125154778.USD","LU2236285917.USD","FTXO","LU1244550494.USD","LU0162691827.USD","LU1791807156.HKD","LU1074936037.SGD","LU0052756011.USD","LU1244550221.USD","PRMN","BK4585","LU0310800965.SGD","LU2360032135.SGD","FDIS","BK4559","LU0072461881.USD","LU0203347892.USD","LU0098860793.USD","LU1162221912.USD","LU1267930227.SGD","LU1244550577.SGD","BK4566","LU1201861249.SGD","LU2456880835.USD","TFNS","LU0477156953.USD","CLSE","ORR","LU0130517989.USD","IYF","WTLS","LU2417539215.USD","SHRT","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656349565","title":"花旗预计，在新能源车批发销量显著提升、行业库存去化明显等利好推动下，中国汽车板块的空头回补势头将持续。","url":"https://stock-news.laohu8.com/highlight/detail?id=2656349565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656349565?lang=zh_cn&edition=full","pubTime":"2026-08-03 08:38","pubTimestamp":1785717532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4207","WTLS","LU1791807156.HKD","BK4559","LU0130102774.USD","LU1244550494.USD","LU0648001328.SGD","LU1074936037.SGD","LU1244550577.SGD","BK4585","LU0170899867.USD","LU1244550221.USD","RTH","CLSE","LU1668664300.SGD","LU0477156953.USD","LU1267930227.SGD","IYF","LU0128525689.USD","ORR","SHRT","BK4588","LU0162691827.USD","LU0203345920.USD","LU0203347892.USD","BK4504","LU2125154935.USD","FTXO","LU2462157665.USD","LU0106831901.USD","LU1162221912.USD","LU2456880835.USD","LU0072461881.USD","LU1201861249.SGD","LU2236285917.USD","LU0098860793.USD","BK4566","LU2417539215.USD","PRMN","SUPL","LU0980610538.SGD","LU2125154778.USD","LU0320765646.SGD","LU1366192091.USD","TFNS","LU1506573853.SGD","LU0314106906.USD","LU0052756011.USD","LU2360032135.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649617065","title":"日本橡胶期货受空头回补及非洲出口限制双重因素提振走高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649617065","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649617065?lang=zh_cn&edition=full","pubTime":"2026-07-06 10:38","pubTimestamp":1783305480,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CLSE","SHRT","RJA","EFFE","ORR","ION","PRMN","FTAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640921641","title":"核心管线数据利空 基石药业股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2640921641","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640921641?lang=zh_cn&edition=full","pubTime":"2026-06-03 07:00","pubTimestamp":1780441200,"startTime":"0","endTime":"0","summary":"6月1日盘前，基石药业（2616.HK）宣布核心资产CS2009（PD-1/VEGF/CTLA-4三特异性抗体）的多项关键临床进展，于美国临床肿瘤学会（ASCO）年会上通过两份壁报正式发布，涵盖一线及后线非小细胞肺癌（NSCLC）及结直肠癌（CRC）患者I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033757998235.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033757998235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4213","CRC","LU0266512127.USD","LU0456854461.SGD","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995293","title":"劲方医药-B公布GFH375治疗癌症疗效数据 ORR达40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995293","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640995293?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:14","pubTimestamp":1780362840,"startTime":"0","endTime":"0","summary":"6月2日，劲方医药-B（02595）发布公告，宣布其GFH375单药治疗KRASG12D突变型胆管癌和结直肠癌的初步疗效数据已于6月1日的ASCO年会上进行口头报告。报告显示，20名KRASG12D突变型胆管癌患者的总体客观缓解率（ORR）为40%，疾病控制率（DCR）为95%。在600mgQD（RP2D）剂量水平的18名患者中，ORR为44.4%，DCR为94.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606023756897496.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606023756897496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02595","ORR","BK1161","BK1515","BK1574","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.0376},{"period":"6month","weight":0.0802},{"period":"1year","weight":0.2147},{"period":"ytd","weight":0.1393}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0551},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1232},{"period":"ytd","weight":0.1287}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"NASDAQ","name":"Militia Long/Short Equity ETF","nameEN":"Militia Long/Short Equity ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Militia Long/Short Equity ETF(ORR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Militia Long/Short Equity ETF(ORR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Militia Long/Short Equity ETF,ORR,Militia Long/Short Equity ETF股票,Militia Long/Short Equity ETF股票老虎,Militia Long/Short Equity ETF股票老虎国际,Militia Long/Short Equity ETF行情,Militia Long/Short Equity ETF股票行情,Militia Long/Short Equity ETF股价,Militia Long/Short Equity ETF股市,Militia Long/Short Equity ETF股票价格,Militia Long/Short Equity ETF股票交易,Militia Long/Short Equity ETF股票购买,Militia Long/Short Equity ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Militia Long/Short Equity ETF(ORR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Militia Long/Short Equity ETF(ORR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}